[HTML][HTML] Coelenterazine-dependent luciferases as a powerful analytical tool for research and biomedical applications

VV Krasitskaya, EE Bashmakova, LA Frank - International Journal of …, 2020 - mdpi.com
The functioning of bioluminescent systems in most of the known marine organisms is based
on the oxidation reaction of the same substrate—coelenterazine (CTZ), catalyzed by …

Luminescence energy transfer–based screening and target engagement approaches for chemical biology and drug discovery

EJ Cho, KN Dalby - SLAS DISCOVERY: Advancing the …, 2021 - journals.sagepub.com
Luminescence is characterized by the spontaneous emission of light resulting from either
chemical or biological reactions. Because of their high sensitivity, reduced background …

Optimization of potent ATAD2 and CECR2 bromodomain inhibitors with an atypical binding mode

SCC Lucas, SJ Atkinson, P Bamborough… - Journal of Medicinal …, 2020 - ACS Publications
Most bromodomain inhibitors mimic the interactions of the natural acetylated lysine (KAc)
histone substrate through key interactions with conserved asparagine and tyrosine residues …

[HTML][HTML] BRET measurement on CCD camera-based microtiter plate readers

KF Cho, N Javier, K Choi - SLAS Discovery, 2022 - Elsevier
NanoBRET assays, which utilize bioluminescence energy resonance transfer (BRET), have
been widely adopted in drug discovery for measuring both protein-protein interactions and …

Measuring Protein–Protein Interactions in Cells using Nanoluciferase Bioluminescence Resonance Energy Transfer (NanoBRET) Assay

MM Szewczyk, DDG Owens… - … : Methods and Protocols, 2023 - Springer
Protein–protein interactions (PPIs) are increasingly recognized for their roles in functional
cellular networks and their importance in disease-targeting contexts. Assessing PPI in the …

Advances in cellular target engagement and target deconvolution

MJ Main, AX Zhang - SLAS DISCOVERY: Advancing the …, 2020 - journals.sagepub.com
116 SLAS Discovery 25 (2) assays can be used in a drug discovery cascade to drive
potency and selectivity. Thus, assays for both compound–target and target–histone …

[HTML][HTML] Development of an intracellular quantitative assay to measure compound binding kinetics

CS Lay, DA Thomas, JP Evans, M Campbell… - Cell chemical …, 2022 - cell.com
Contemporary drug discovery typically quantifies the effect of a molecule on a biological
target using the equilibrium-derived measurements of IC 50, EC 50, or K D. Kinetic …

[HTML][HTML] Kinetic intracellular assay measures compound binding kinetics at intracellular targets within living cells

CS Lay, DA Thomas, PD Craggs - Future Drug Discovery, 2021 - Taylor & Francis
The significance of measuring association and dissociation rates (kon and koff) in addition
the dissociation constant (KD) when designing and developing new chemical entities is now …

[HTML][HTML] A kinetic intra-cellular assay (KICA) to measure quantitative compound binding kinetics within living cells

CS Lay, DA Thomas, JP Evans, EJ Jones, KM Gatfield… - STAR protocols, 2022 - Elsevier
Summary The Kinetic Intra-Cellular Assay (KICA) is a recombinant cell-based technique that
utilizes NanoBRET technology. KICA enables the measurement of intracellular binding …

[引用][C] Cellular target engagement assays for small-molecule drug discovery

A Delwig, N Ishisoko, RA Blake - 2022 Medicinal Chemistry …, 2022 - ACS Publications